메뉴 건너뛰기




Volumn 166, Issue 2, 2013, Pages

Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 84880916987     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.05.008     Document Type: Article
Times cited : (46)

References (16)
  • 1
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 19 1998 1349 1357
    • (1998) N Engl J Med , vol.339 , Issue.19 , pp. 1349-1357
  • 5
    • 84865602423 scopus 로고    scopus 로고
    • Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
    • M. Tonelli, P. Muntner, and A. Lloyd Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 2012
    • (2012) Lancet
    • Tonelli, M.1    Muntner, P.2    Lloyd, A.3
  • 6
    • 76649140800 scopus 로고    scopus 로고
    • Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry
    • C.S. Fox, P. Muntner, and A.Y. Chen Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation 121 3 2010 357 365
    • (2010) Circulation , vol.121 , Issue.3 , pp. 357-365
    • Fox, C.S.1    Muntner, P.2    Chen, A.Y.3
  • 9
    • 70350245011 scopus 로고    scopus 로고
    • Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of Obesity
    • K.G. Alberti, R.H. Eckel, and S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 2009 1640 1645
    • (2009) Circulation , vol.120 , Issue.16 , pp. 1640-1645
    • Alberti, K.G.1    Eckel, R.H.2    Grundy, S.M.3
  • 10
    • 65649142017 scopus 로고    scopus 로고
    • A new equation to estimate glomerular filtration rate
    • A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
    • (2009) Ann Intern Med , vol.150 , Issue.9 , pp. 604-612
    • Levey, A.S.1    Stevens, L.A.2    Schmid, C.H.3
  • 11
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • A.S. Levey, J. Coresh, and E. Balk National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2 2003 137 147
    • (2003) Ann Intern Med , vol.139 , Issue.2 , pp. 137-147
    • Levey, A.S.1    Coresh, J.2    Balk, E.3
  • 12
    • 0344444877 scopus 로고    scopus 로고
    • Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee
    • R.V. Luepker, F.S. Apple, and R.H. Christenson Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 20 2003 2543 2549
    • (2003) Circulation , vol.108 , Issue.20 , pp. 2543-2549
    • Luepker, R.V.1    Apple, F.S.2    Christenson, R.H.3
  • 13
    • 57649111142 scopus 로고    scopus 로고
    • The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years
    • A. Rashidi, A.R. Sehgal, and M. Rahman The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol 102 12 2008 1668 1673
    • (2008) Am J Cardiol , vol.102 , Issue.12 , pp. 1668-1673
    • Rashidi, A.1    Sehgal, A.R.2    Rahman, M.3
  • 14
    • 82355175158 scopus 로고    scopus 로고
    • AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation
    • S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 22 2011 2458 2473
    • (2011) Circulation , vol.124 , Issue.22 , pp. 2458-2473
    • Smith, Jr.S.C.1    Benjamin, E.J.2    Bonow, R.O.3
  • 15
    • 79959746706 scopus 로고    scopus 로고
    • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
    • C. Baigent, M.J. Landray, and C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
    • (2011) Lancet , vol.377 , Issue.9784 , pp. 2181-2192
    • Baigent, C.1    Landray, M.J.2    Reith, C.3
  • 16
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
    • (2005) Lancet , vol.366 , Issue.9493 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.